BlackRock’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42.5K | Hold |
663
| – | – | ﹤0.01% | 4947 |
|
|
2025
Q1 | $42.1K | Hold |
663
| – | – | ﹤0.01% | 4902 |
|
|
2024
Q4 | $44.1K | Buy |
663
+450
| +211% | +$29.9K | ﹤0.01% | 4920 |
|
|
2024
Q3 | $14.9K | Hold |
213
| – | – | ﹤0.01% | 4914 |
|
|
2024
Q2 | $13.8K | Hold |
213
| – | – | ﹤0.01% | 4990 |
|
|
2024
Q1 | $13.8K | Hold |
213
| – | – | ﹤0.01% | 4997 |
|
|
2023
Q4 | $14K | Hold |
213
| – | – | ﹤0.01% | 5046 |
|
|
2023
Q3 | $12.1K | Hold |
213
| – | – | ﹤0.01% | 5119 |
|
|
2023
Q2 | $13.1K | Hold |
213
| – | – | ﹤0.01% | 5150 |
|
|
2023
Q1 | $13.4K | Hold |
213
| – | – | ﹤0.01% | 5216 |
|
|
2022
Q4 | $13.5K | Hold |
213
| – | – | ﹤0.01% | 5340 |
|
|
2022
Q3 | $13K | Hold |
213
| – | – | ﹤0.01% | 5479 |
|
|
2022
Q2 | $12K | Hold |
213
| – | – | ﹤0.01% | 5516 |
|
|
2022
Q1 | $13K | Hold |
213
| – | – | ﹤0.01% | 5531 |
|
|
2021
Q4 | $15K | Hold |
213
| – | – | ﹤0.01% | 5500 |
|
|
2021
Q3 | $16K | Hold |
213
| – | – | ﹤0.01% | 5357 |
|
|
2021
Q2 | $16K | Hold |
213
| – | – | ﹤0.01% | 5238 |
|
|
2021
Q1 | $16K | Buy |
+213
| New | +$16K | ﹤0.01% | 4986 |
|